Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 31.07.2025
Nemetschek SE
Corporate News
Nemetschek Group: Q2 2025 with very strong revenue growth of +30.5% (currency-adjusted) and high profitability; revenue outlook for 2025 increased
+30.5% revenue growth (currency-adjusted) in Q2 to EUR 290.0 million (organic growth excluding GoCanvas: +21.6%)
+72.5% currency-adjusted growth in Q2 in subscription/SaaS to EUR 208.5 [ … ]
Thu, 31.07.2025
Medacta Group SA
Media Release – Ad-hoc announcement pursuant to Art. 53 LR
Medacta Group SA reports continued above-market revenue growth of 19.8% in c.c.1 in H1 2025 and upgrades its FY 2025 and mid-term guidance
H1 2025 revenue accelerated to Euro 344.1 million, up 19.8% in c.c.1 or 19.2% in Euro
Substantial revenue growth across a [ … ]
Thu, 31.07.2025
Knorr-Bremse Aktiengesellschaft
Knorr-Bremse Delivers Strong, Compelling H1 Performance
Operating EBIT up at € 498 million, with higher operating EBIT margin of 12.6%
Sustained high level of demand in the first half of 2025: order intake at € 4.5 billion, order book close to record level at € 7.3 billion
Revenues at approximately € 4 billion
Free cash flow up significantly [ … ]
Thu, 31.07.2025
AT&S Austria Technologie & Systemtechnik AG
AT&S shows upward trend in the first quarter
Revenue increases to € 399 million in Q1 2025/26, up 14% on the prior-year quarter
EBITDA of € 71 million corresponds to a margin of 17.7%
Revenue, earnings and equity strongly impacted by foreign exchange development
Half-year forecast: revenue € 820 million, EBITDA margin 20%
Outlook fo [ … ]
Thu, 31.07.2025
Aperam S.A.
Aperam S.A.
/ Key word(s): Quarter Results
Aperam - Second quarter 2025 results : “Delivering on Promises despite Headwinds” 31-Jul-2025 / 06:58 CET/CEST
Second quarter 2025 results1
“Delivering on Promises despite Headwinds”
Luxembourg, July 31, 2025 (07:00 CEST) - Aperam S.A. (referred to as “Aperam” or the “Company [ … ]
Thu, 31.07.2025
Comet Holding AG
Ad hoc announcement pursuant to Art. 53 LR
First half of 2025
Net sales of CHF 227.2 million for the Group, 20.0% higher than a year earlier
(HY24: CHF 189.3 million); +42.4% for PCT division
EBITDA margin of 9.1%, compared to 6.9% in HY24
Book-to-bill of 0.98 (HY24: 1.10)
Outlook for second half of 2025
Semiconductor industry impacted by ma [ … ]
Thu, 31.07.2025
Avolta AG
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Delivering on all KPIs with +7.1% CER revenue growth, a CORE EBITDA margin of 9.3%, EPS growth of +28.7% and CHF 216m EFCF. Avolta reaffirms its medium-term outlook.
H1 2025 HIGHLIGHTS:
Strong financial performance H1 2025
Turnover reported CHF 6,734m, CORE CHF 6,613m
CORE revenue growth +7.1% CER1, [ … ]
Thu, 31.07.2025
Holcim Group Services Ltd
Recurring EBIT up +10.8% in local currencyNet sales up +1.8% in local currency
Recurring EBIT margin of 18.3%, up +90 bps
+7.4% growth in EPS before impairment and divestments
Disciplined M&A execution continues with 11 value-accretive transactions
Confident FY2025 guidance following spin-off completion, in line with NextGen Growth 2030 targets [ … ]
Thu, 31.07.2025
Interroll Holding AG
Stable sales at CHF 247.7 million, up 3.6% in local currencies, despite a low order intake in H2/2024
Order intake stabilized at CHF 284.1 million, up 2.7% in local currencies
With increased investments in R&D and marketing for future growth and innovation, EBIT margin at 11.1% (previous year: 12.1%)
Secured landmark orders with leading glob [ … ]
Thu, 31.07.2025
Curatis Holding AG
Curatis Holding AG
/ Key word(s): Legal Matter/Strategic Company Decision
FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study
31.07.2025 / 06:00 CET/CEST
MEDIA RELEASE
Liestal, Switzerland– Curatis Holding AG (SIX: CURN) – July 31, 2025. The U.S. Food and Drug Administration (FDA) have agreed to a Type B m [ … ]
